MRI accessories developer IRadimed has received U.S. Food and Drug Administration (FDA) 510(k) clearance for neonatal use of its SpO2 pulse oximetry and CO2 capnography monitoring features on its 3880 MRI-compatible patient vital signs monitoring system.
IRadimed designed the system with nonmagnetic components and other features to monitor a patient's vital signs during various MRI procedures. It also can operate magnetic fields up to 30,000 gauss in an MRI suite, according to the company. Its compact and lightweight design allows for uninterrupted monitoring during transport of critically ill patients.
